Approval for the BioMimics 3D Vascular Stent System.  The device is indicated to improve luminal diameter in the treatment of symptomatic de novo or restenotic lesions in the native superficial femoral artery and/or proximal popliteal arteries, with reference vessel diameters ranging from 4.0 - 6.0 mm and lesion lengths up to 140 mm.